New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery

NEUCHATEL, Switzerland–(BUSINESS WIRE)–Feb. 27, 2017–
Masimo (NASDAQ:
MASI) announced today the findings of a recent study conducted on
low-risk patients undergoing colorectal surgery, in which researchers
assessed the utility of noninvasive and continuous Masimo PVi®
(Pleth Variability Index) monitoring to guide fluid management, as
compared to esophageal Doppler, an invasive method. The researchers
found no significant difference between the two technologies in mean
total fluid administered and concluded that “PVi offers an entirely
noninvasive alternative for goal-directed therapy in this group of
patients.”1

Más información: New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery